MedTrace Logo

Growth and Tolerance of Healthy Term Infants to a New Infant Formula

NCT01137877 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 399

Last updated 2010-11-25

No results posted yet for this study

Summary

The objective of this study is to evaluate the effect of two experimental milk-based infant formulas on the growth and gastrointestinal (GI) tolerance of term infants.

Conditions

  • Healthy Term Infants

Interventions

OTHER

Milk based infant formula powder

milk based infant formula ad lib

OTHER

Investigational Infant Formula #1

Milk based infant formula ad lib

OTHER

Investigational Infant Formula #2

Milk based infant formula powder ad lib

OTHER

Human Milk

Human milk ad lib

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Timberly Williams, PhD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
11 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01137877 on ClinicalTrials.gov